| 产品名称： | LBRM-33-1A5 |
|---|---|
| 商品货号： | TS211657 |
| Organism： | Mus musculus, mouse |
| Tissue： | spleen |
| Product Format： | frozen |
| Morphology： | lymphoblast |
| Culture Properties： | suspension |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disease： | lymphoma |
| Strain： | B10.BR |
| Applications： | The cells produce IL-2 in response to IL-1, and can be used to assay IL-1 activity. |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Receptor Expression： | interleukin 1 (IL-1) |
| Genes Expressed： | interleukin-2 (interleukin 2, IL-2) |
| Cellular Products： | interleukin-2 (interleukin 2, IL-2) |
| Comments： | The cells produce IL-2 in response to IL-1, and can be used to assay IL-1 activity. |
| Complete Growth Medium： | RPMI 1640 medium with 0.0025 mM 2-mercaptoethanol, 90%; fetal bovine serum, 10%
|
| Subculturing： | Medium Renewal: Every 2 to 3 days Cultures can be maintained by addition or replacement of fresh medium. Adherent cells can be dislodged by scraping. Maintain at approximately 8 X 10 exp5 viable cells/ml. |
| Name of Depositor： | S Gillis |
| U.S. Patent Number： | |
| References： | Gillis S. Process for preparing murine interleukin-2 in the presence of interleukin-1 from an interleukin-2 nonproducer malignant cell line and cell line therefor. US Patent 4,404,280 dated Sep 13 1983 |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | LBRM-33-1A5 |
|---|---|
| 商品货号： | TS211657 |
| Organism： | Mus musculus, mouse |
| Tissue： | spleen |
| Product Format： | frozen |
| Morphology： | lymphoblast |
| Culture Properties： | suspension |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disease： | lymphoma |
| Strain： | B10.BR |
| Applications： | The cells produce IL-2 in response to IL-1, and can be used to assay IL-1 activity. |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Receptor Expression： | interleukin 1 (IL-1) |
| Genes Expressed： | interleukin-2 (interleukin 2, IL-2) |
| Cellular Products： | interleukin-2 (interleukin 2, IL-2) |
| Comments： | The cells produce IL-2 in response to IL-1, and can be used to assay IL-1 activity. |
| Complete Growth Medium： | RPMI 1640 medium with 0.0025 mM 2-mercaptoethanol, 90%; fetal bovine serum, 10%
|
| Subculturing： | Medium Renewal: Every 2 to 3 days Cultures can be maintained by addition or replacement of fresh medium. Adherent cells can be dislodged by scraping. Maintain at approximately 8 X 10 exp5 viable cells/ml. |
| Name of Depositor： | S Gillis |
| U.S. Patent Number： | |
| References： | Gillis S. Process for preparing murine interleukin-2 in the presence of interleukin-1 from an interleukin-2 nonproducer malignant cell line and cell line therefor. US Patent 4,404,280 dated Sep 13 1983 |
